论文部分内容阅读
世界卫生组织 (ＷＨＯ)和美国疾病控制和预防中心 (ＣＤＣ)鉴于慢性肝病病人患获得性甲型肝炎 (ＨＡ)有较高的病死率 ,故建议此类病人应进行ＨＡ疫苗接种。本研究的目的旨在评估肝衰竭和肝移植的慢性肝病病人行ＨＡ疫苗接种的安全性和免疫原性。材料与方法 应用酶免疫技术测定
The World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) recommend that patients should be vaccinated for HA in view of their higher mortality from acquired Hepatitis A (HA) in patients with chronic liver disease. The purpose of this study was to evaluate the safety and immunogenicity of HA vaccination in patients with liver failure and liver transplantation for chronic liver disease. Materials and Methods Determination of enzyme immunoassay